Sector revisions Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 11:54:00 2026-09-08 am EDT			5-day change	1st Jan Change
243.70 ^EUR	-1.50%		-1.13%	+42.51%

09:24am	Charles River Laboratories International Implements Endosafe Cartridge Technology Automated Manufacturing Suite	CI
Aug. 20	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		20
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
CELLTRION, INC.		22
ASCENDIS PHARMA A/S	-	20
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
TEMPUS AI, INC.		15
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
PRAXIS PRECISION MEDICINES, INC.		19
ABIVAX		6
KYMERA THERAPEUTICS, INC.		21
IONIS PHARMACEUTICALS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		14
Average		17
Weighted average by Cap.		19